Literature DB >> 15364221

Inflammatory orbital pseudotumor with extension beyond the orbit.

Michael A Mahr1, Diva R Salomao, James A Garrity.   

Abstract

PURPOSE: To summarize the clinical profile and response to treatment of 4 biopsy-proven cases of inflammatory orbital pseudotumor extending beyond the orbit.
DESIGN: Retrospective observational case series.
METHODS: Four patients' charts were retrospectively reviewed. There were three men with extraorbital extension (two intracranial; one maxillary antrum) and one woman with intracranial disease that extended into the orbit. The men were 40, 41, and 60 years old; the woman was 73 years old.
RESULTS: Two men with orbital myositis and mild discomfort, initially treated with corticosteroids, had asymptomatic intracranial disease 9 and 12 months after initial presentation. A third man had extension into the maxillary antrum after initial symptoms of painless diplopia. The woman had intraorbital disease with minimal discomfort (dacryoadenitis and myositis) 5 years after presenting with intracranial disease in the Meckel cave that subsequently became bilateral. Histopathologic examination in all cases showed nonspecific inflammation without evidence of vasculitis or granulomas.
CONCLUSIONS: Unlike typical cases of nonspecific orbital inflammation, two of these four cases did not have pain as a prominent feature. Neuroimaging was essential in diagnosing asymptomatic extraorbital disease. Surgery has a prominent role in confirming this diagnosis, primarily by helping to rule out other diseases, such as those with granulomatous inflammation or vasculitis. Additional therapy was usually not required postoperatively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364221     DOI: 10.1016/j.ajo.2004.04.026

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Inflammatory myofibroblastic tumor of the orbit with associated enhancement of the meninges and multiple cranial nerves.

Authors:  A M McKinney; J Short; L Lucato; K SantaCruz; Z McKinney; Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 2.  Inflammatory pseudotumor of the cavernous sinus and skull base.

Authors:  Todd McCall; Daniel R Fassett; George Lyons; William T Couldwell
Journal:  Neurosurg Rev       Date:  2006-03-25       Impact factor: 3.042

3.  Relationship between dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis.

Authors:  Jing Li; Xin Ge; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

4.  Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach.

Authors:  Ilse Mombaerts; Jurij R Bilyk; Geoffrey E Rose; Alan A McNab; Aaron Fay; Peter J Dolman; Richard C Allen; Martin H Devoto; Gerald J Harris
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

5.  Not a Tumor-Nonspecific Orbital Inflammation.

Authors:  James A Garrity
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-02

6.  Paranasal sinus inflammation and non-specific orbital inflammatory syndrome: an uncommon association.

Authors:  Igal Leibovitch; Robert A Goldberg; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-22       Impact factor: 3.117

7.  Idiopathic orbital inflammatory disease.

Authors:  Mary K Jacob
Journal:  Oman J Ophthalmol       Date:  2012-05

8.  Inflammatory pseudotumor of the head presenting with hemiparesis and aphasia.

Authors:  K Saifudheen; James Jose; V Abdul Gafoor
Journal:  Case Rep Neurol Med       Date:  2011-07-14

9.  Atypical presentation of orbital pseudotumor with visual loss as an initial manifestation.

Authors:  Recai Turkoglu; Naci Balak
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

Review 10.  Intracranial extension of orbital inflammatory pseudotumor: a case report and literature review.

Authors:  Enrico Tedeschi; Lorenzo Ugga; Ferdinando Caranci; Francesca Califano; Sirio Cocozza; Giacomo Lus; Arturo Brunetti
Journal:  BMC Neurol       Date:  2016-02-29       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.